Biological fingerprints improve diagnosis of dementia

October 4, 2011

Differentiating between the various forms of dementia is crucial for initiating appropriate treatment. Researchers at the Sahlgrenska Academy have discovered that the underlying diseases leave different "fingerprints" in the cerebrospinal fluid, paving the way for more reliable diagnoses.

The two most common forms of dementia are Alzheimer's disease and . The latter is caused by reduced circulation in the small blood vessels of the brain, which can be picked up in as small infarcts -- strokes -- or widespread changes in the white matter. The problem is that this small vessel disease presents very similarly to Alzheimer's disease, making it difficult in practice to distinguish between the two.

Biochemical fingerprints in CSF

Because the different diseases are treated differently, it is important to be able to make the . Researcher Maria Bjerke from the Sahlgrenska Academy at the University of Gothenburg has shown in her thesis that the different forms of dementia are detectable as in the (CSF) long before any clinical symptoms emerge. The results are significant for how the most common age-related cognitive disorders are diagnosed.

Step towards better treatment

"As the CSF is in direct contact with the brain, its can be expected to reflect the brain's metabolism," Bjerke explains. "Examining the molecular fingerprints in the CSF enables us to determine whether or not there is an ongoing pathological process".

"Mapping the biochemical differences between the various forms of dementia will help us to understand what caused the disease, which in turn will determine how the disease should be treated."

The possibility of differentiating between patients with mild cognitive disorders due to small vessel disease and patients with Alzheimer's needs to be given much greater attention, Bjerke believes, not least with a view to designing and implementing detailed treatment studies.

Explore further: Biomarkers for Alzheimer's disease can be trusted in clinical trials

More information: The thesis Cerebrospinal fluid biomarkers for differentiating between Alzheimer's disease and vascular dementia was successfully defended on 9 June 2011.

Related Stories

Education helps against dementia

May 31, 2010

Researchers have discovered that education not only delays the early symptoms of dementia, but can also slow down the development of the disease - a finding that could result in faster diagnosis and treatment of dementia, ...

New clues to the cause of Alzheimer's disease

June 30, 2011

Researchers at the Sahlgrenska Academy, University of Gothenburg, have identified a series of novel proteins in human cerebrospinal fluid. The proteins, which carry specific sugar molecules, are found in greater concentrations ...

Recommended for you

Team discovers how Zika virus causes fetal brain damage

August 24, 2016

Infection by the Zika virus diverts a key protein necessary for neural cell division in the developing human fetus, thereby causing the birth defect microcephaly, a team of Yale scientists reported Aug. 24 in the journal ...

Immune breakthrough: Unscratching poison ivy's rash

August 23, 2016

We all know that a brush with poison ivy leaves us with an itchy painful rash. Now, Monash University and Harvard researchers have discovered the molecular cause of this irritation. The finding brings us a step closer to ...

Zika infection may affect adult brain cells

August 18, 2016

Concerns over the Zika virus have focused on pregnant women due to mounting evidence that it causes brain abnormalities in developing fetuses. However, new research in mice from scientists at The Rockefeller University and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.